Matches in SemOpenAlex for { <https://semopenalex.org/work/W2795069907> ?p ?o ?g. }
- W2795069907 abstract "Abstract Reversal of cancer gene expression is predictive of therapeutic potential and can be used to find new indications for existing drugs (drug repositioning). Gene expression reversal potential is currently calculated, in almost all studies, by pre-aggregating all tumour samples into a single group signature or a limited number of molecular subtype signatures. Here, we investigate whether drug repositioning based on individual tumour sample gene expression signatures outperforms the use of tumour group and subtype signatures. The tumour signatures were created using 534 tumour samples and 72 matched normal samples from 530 clear cell renal cell carcinoma (ccRCC) patients. More than 20,000 drug signatures were extracted from the CMAP and LINCS databases. We show that negative enrichment of individual tumour samples correlated (Spearman’s rho = 0.15) much better with the amount of differentially expressed genes in drug signatures than with the tumour group signature (Rho = 0.08) and the 4 tumour subtype signatures (Rho 0.036-0.11). Targeted drugs used against ccRCC, such as sirolimus and temsirolimus, which could not be identified with the pre-aggregated tumour signatures could be recovered using individual sample analysis. Thus, drug repositioning can be personalized by taking into account the gene expression profile of the individual’s tumour sample." @default.
- W2795069907 created "2018-04-06" @default.
- W2795069907 creator A5003146560 @default.
- W2795069907 creator A5016113617 @default.
- W2795069907 creator A5026977671 @default.
- W2795069907 creator A5030957904 @default.
- W2795069907 creator A5083260131 @default.
- W2795069907 date "2018-03-27" @default.
- W2795069907 modified "2023-09-25" @default.
- W2795069907 title "Personalised drug repositioning for Clear Cell Renal Cell Carcinoma using gene expression" @default.
- W2795069907 cites W1852538637 @default.
- W2795069907 cites W2035240798 @default.
- W2795069907 cites W2045949302 @default.
- W2795069907 cites W2062941476 @default.
- W2795069907 cites W2070734974 @default.
- W2795069907 cites W2081886885 @default.
- W2795069907 cites W2116650193 @default.
- W2795069907 cites W2123431502 @default.
- W2795069907 cites W2137632714 @default.
- W2795069907 cites W2146512944 @default.
- W2795069907 cites W2151357092 @default.
- W2795069907 cites W2166458281 @default.
- W2795069907 cites W2168342464 @default.
- W2795069907 cites W2174011260 @default.
- W2795069907 cites W2230320310 @default.
- W2795069907 cites W2261944919 @default.
- W2795069907 cites W2335012284 @default.
- W2795069907 cites W2412921667 @default.
- W2795069907 cites W2466314544 @default.
- W2795069907 cites W2565408756 @default.
- W2795069907 cites W2568779902 @default.
- W2795069907 cites W2613973024 @default.
- W2795069907 cites W2726542547 @default.
- W2795069907 cites W2734505834 @default.
- W2795069907 cites W4241872665 @default.
- W2795069907 cites W587018455 @default.
- W2795069907 cites W617288073 @default.
- W2795069907 doi "https://doi.org/10.1038/s41598-018-23195-8" @default.
- W2795069907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5869697" @default.
- W2795069907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29588458" @default.
- W2795069907 hasPublicationYear "2018" @default.
- W2795069907 type Work @default.
- W2795069907 sameAs 2795069907 @default.
- W2795069907 citedByCount "13" @default.
- W2795069907 countsByYear W27950699072018 @default.
- W2795069907 countsByYear W27950699072019 @default.
- W2795069907 countsByYear W27950699072020 @default.
- W2795069907 countsByYear W27950699072021 @default.
- W2795069907 countsByYear W27950699072022 @default.
- W2795069907 countsByYear W27950699072023 @default.
- W2795069907 crossrefType "journal-article" @default.
- W2795069907 hasAuthorship W2795069907A5003146560 @default.
- W2795069907 hasAuthorship W2795069907A5016113617 @default.
- W2795069907 hasAuthorship W2795069907A5026977671 @default.
- W2795069907 hasAuthorship W2795069907A5030957904 @default.
- W2795069907 hasAuthorship W2795069907A5083260131 @default.
- W2795069907 hasBestOaLocation W27950699071 @default.
- W2795069907 hasConcept C103637391 @default.
- W2795069907 hasConcept C104317684 @default.
- W2795069907 hasConcept C142724271 @default.
- W2795069907 hasConcept C143998085 @default.
- W2795069907 hasConcept C150194340 @default.
- W2795069907 hasConcept C162317418 @default.
- W2795069907 hasConcept C183713625 @default.
- W2795069907 hasConcept C2776820818 @default.
- W2795069907 hasConcept C2777472916 @default.
- W2795069907 hasConcept C2777546739 @default.
- W2795069907 hasConcept C2779733811 @default.
- W2795069907 hasConcept C2780035454 @default.
- W2795069907 hasConcept C2781278892 @default.
- W2795069907 hasConcept C502942594 @default.
- W2795069907 hasConcept C54355233 @default.
- W2795069907 hasConcept C62478195 @default.
- W2795069907 hasConcept C70721500 @default.
- W2795069907 hasConcept C71924100 @default.
- W2795069907 hasConcept C86554907 @default.
- W2795069907 hasConcept C86803240 @default.
- W2795069907 hasConcept C98274493 @default.
- W2795069907 hasConceptScore W2795069907C103637391 @default.
- W2795069907 hasConceptScore W2795069907C104317684 @default.
- W2795069907 hasConceptScore W2795069907C142724271 @default.
- W2795069907 hasConceptScore W2795069907C143998085 @default.
- W2795069907 hasConceptScore W2795069907C150194340 @default.
- W2795069907 hasConceptScore W2795069907C162317418 @default.
- W2795069907 hasConceptScore W2795069907C183713625 @default.
- W2795069907 hasConceptScore W2795069907C2776820818 @default.
- W2795069907 hasConceptScore W2795069907C2777472916 @default.
- W2795069907 hasConceptScore W2795069907C2777546739 @default.
- W2795069907 hasConceptScore W2795069907C2779733811 @default.
- W2795069907 hasConceptScore W2795069907C2780035454 @default.
- W2795069907 hasConceptScore W2795069907C2781278892 @default.
- W2795069907 hasConceptScore W2795069907C502942594 @default.
- W2795069907 hasConceptScore W2795069907C54355233 @default.
- W2795069907 hasConceptScore W2795069907C62478195 @default.
- W2795069907 hasConceptScore W2795069907C70721500 @default.
- W2795069907 hasConceptScore W2795069907C71924100 @default.
- W2795069907 hasConceptScore W2795069907C86554907 @default.
- W2795069907 hasConceptScore W2795069907C86803240 @default.
- W2795069907 hasConceptScore W2795069907C98274493 @default.
- W2795069907 hasIssue "1" @default.